$NLNK Company News Small victories recorded in fight

New Post Public Reply Private Reply Replies (0) Message Board

Oct 20, 2014 at 2:18 PM

$NLNK Company News

Small victories recorded in fight against Ebola 12:22 p.m. Today - Russ Britt
Sarepta says its Ebola drug has no ill effects 5:28 p.m. Oct. 16, 2014 - Russ Britt
Two biotechs staking claim in fight against Ebola 4:06 p.m. Oct. 16, 2014 - Russ Britt
Is there an Ebola bubble in these stocks? 3:22 p.m. Oct. 16, 2014 - Wallace Witkowski
AMD shares drop after hours 6:51 p.m. Oct. 13, 2014 - Wallace Witkowski
Fight against Ebola spreads to other nations 4:42 p.m. Oct. 13, 2014 - Russ Britt
Newlink shares jump on start of Ebola vaccine study 4:14 p.m. Oct. 13, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 12:09 p.m. Oct. 13, 2014 - The Trading Deck
Ebola vaccine use likely to be confined, experts say 7:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 4:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 4:14 p.m. Oct. 3, 2014 - Russ Britt
Tesla climbs on product hint; Constellation falls 8:07 a.m. Oct. 2, 2014 - Ben Eisen
Getting Ebola treatments to market may take time 3:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 8:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 8:13 a.m. Oct. 1, 2014 - Ben Eisen
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
9 IPOs on tap; Angie's List, Delphi lead 2:11 p.m. Nov. 12, 2011 - MarketWatch.com

Why NewLink Genetics (NLNK) Stock Is Soaring Today 10:41 a.m. Today - TheStreet.com
Heavy Trading On NewLink Genetics (NLNK) Before Market Open 9:16 a.m. Today - TheStreet.com
New Link Genetics and Genentech team up in cancer immunotherapy 7:51 a.m. Today - Seeking Alpha
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement For Development Of NLG919, An IDO Inhibitor In Phase 1, And Research Collaboration For The Discovery Of Next Generation IDO/TDO Inhibitors 6:01 a.m. Today - benzinga.com
Ebola Vaccine Push Ramps Up 7:54 p.m. Oct. 19, 2014 - The Wall Street Journal Interactive Edition
Canada Ships Out Experimental Ebola Vaccine 4:28 p.m. Oct. 18, 2014 - The Wall Street Journal Interactive Edition
Stomach-Churning Ride for Ebola Stocks 2:52 p.m. Oct. 17, 2014 - FOXBusiness
Healthcare Stocks in Focus on Ebola Fears - Analyst Blog 2:34 p.m. Oct. 17, 2014 - Zacks.com
Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback 1:50 p.m. Oct. 17, 2014 - TheStreet.com
Obama appoints Ebola czar 1:35 p.m. Oct. 17, 2014 - Seeking Alpha
Making Money With Charles Payne: 10/16/14 6:00 p.m. Oct. 16, 2014 - FOXBusiness
Roller coaster ride continues for Ibio 9:09 a.m. Oct. 16, 2014 - Seeking Alpha
Second Texas Ebola case stokes the index 8:57 a.m. Oct. 15, 2014 - Seeking Alpha
Second healthcare worker contracts Ebola in U.S. 5:25 a.m. Oct. 15, 2014 - Seeking Alpha
Stock To Watch: NewLink Genetics (NLNK) In Perilous Reversal 10:11 a.m. Oct. 14, 2014 - TheStreet.com
NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape 9:46 a.m. Oct. 14, 2014 - Zacks.com
Canada Launches Clinical Trials of Ebola Vaccine 1:54 p.m. Oct. 13, 2014 - The Wall Street Journal Interactive Edition
Ibio jumps on possible ZMapp production ramp 4:18 p.m. Oct. 10, 2014 - Seeking Alpha
Trade-Ideas: NewLink Genetics (NLNK) Is Today's Strong On High Relative Volume Stock 10:02 a.m. Oct. 10, 2014 - TheStreet.com
Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear 1:38 p.m. Oct. 9, 2014 - Investors Business Daily

NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 8:22 a.m. Today - eTeligis
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - GlobeNewswire
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:01 a.m. Today - Marketwired
Critical Alerts For NewLink Genetics, Orexigen Therapeutics, JinkoSolar, Randgold Resources and Arrowhead Research Released By InvestorsObserver 9:31 a.m. Oct. 16, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NewLink Genetics Corporation - NLNK 1:55 p.m. Oct. 2, 2014 - PR Newswire - PRF
Critical Alerts For AT&T, NewLink Genetics, Acuity Brands, Quintiles and Finish Line Released By InvestorsObserver 9:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:22 p.m. Oct. 1, 2014 - Marketwire
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer 5:14 p.m. Oct. 1, 2014 - eTeligis
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:16 a.m. Sept. 4, 2014 - Marketwire
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine 7:01 a.m. Sept. 4, 2014 - eTeligis
Small companies lead the I-O class of Cancer Therapies 8:03 a.m. Aug. 8, 2014 - ACCESSWIRE
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:16 a.m. Aug. 5, 2014 - Marketwire
NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine 7:01 a.m. Aug. 5, 2014 - eTeligis
NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results 7:17 p.m. Aug. 4, 2014 - eTeligis
NewLink Genetics to Present at the XVIth International Congress of Virology 7:15 a.m. July 28, 2014 - Marketwire
NewLink Genetics to Present at the XVIth International Congress of Virology 7:00 a.m. July 28, 2014 - eTeligis
Biotech Equities Ahead of Market -- Research on Vertex Pharma, NewLink Genetics, ImmunoGen, and Synta Pharma 7:20 a.m. June 5, 2014 - PR Newswire - PRF
NewLink Genetics Demonstrates Continuing IDO Pathway Inhibitor Progress at ASCO 2014 Annual Meeting 2:35 a.m. June 5, 2014 - Marketwire
NewLink Genetics Dorgenmeltucel-L HyperAcute Immunotherapy for Melanoma Demonstrates Clinical Efficacy With Tumor Regression and Immune Activation 7:11 a.m. May 30, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Deadline Looms: Investors, Wake Up!

A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...

Buyers Edge Appoints Sam Peterson as CTO to Lead AI Shift

Anticipating a New Era of AI with Buyers Edge The rumble through the procurement world was more of a jolt this week as Buyers Edge Platform (BEP) threw a new player into the tech gauntlet. Sam Peterson has been handed the reins as the Chief Technology Officer. The goal? To supercharge BEP's innovation engine with some AI-driven gusto. What's in the Cards for Buyers Edge...

BAILOR Welcomes Co-Founder Bob Bailor to Coach Academy

A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...

Investigations Target PAG, BRBS, PSNL for Fair Shareholder Deals

Unpacking the Shareholder's Dilemma in Major Transactions Alright, folks, let's dig into this mess with our favorite Wall Street magnifying glass. We've got Penske Automotive Group (NYSE: PAG), Blue Ridge Bankshares (NYSE: BRBS), and Personalis, Inc. (NASDAQ: PSNL) under the spotlight, each locking themselves into deals that might not exactly scream 'fair play' for the...

Nanoscope Therapeutics Aims for Eye-Catching Advances

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Triskell's 2026 Update: AI Leverages Portfolio Data

Triskell's Strategic AI Leap Forward Forget the old grind of manual data tinkering—Triskell Software's latest AI enhancements in their 2026 SP2 release are setting a new stage. The Spain-based outfit is tweaking their Project Portfolio Management tools under the hood to suit modern instincts. It seems like portfolio management is getting a brain boost with some added AI...

Aries Unveils Prediction Markets Amid Midterm Fervor

Aries Enters Prediction Markets Ah, Aries is diving into the world of prediction markets, riding the wave of excitement around the 2026 U.S. midterm elections. They're tossing their hat in the ring with Aries Mobile, letting eligible customers toy with event contracts on not just political outcomes, but economic data and financial market trends too. With ForecastEx LLC,...

California Housing Affordability Stagnant as Rates Rise

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...

Legal Bay's Year-End Cash Lifeline Amid Financial Strain

Legal Bay's Holiday Break for Plaintiffs Let's face it, waiting for a lawsuit to wrap up while bills stack up is about as comfortable as sitting on pins and needles. And smack in the middle of this drag, here come the holidays. Overspending on gifts, whopping travel costs, maybe some unexpected tuition bills—suddenly, the bank account's looking as bleak as a rainy...

Co-op Giants Earn $309B: Key Players Spotlighted

Co-ops Punch Above Their Weight Forget the tired stereotypes about co-ops as small-time players. The NCB Co-op 100® Report lands like a punch with a staggering revelation: $309 billion in revenue for 2025. That's no small potatoes, and it shows these cooperatives, sprinkled across agriculture, finance, and beyond, are no shy creatures—they're major contenders in...